340B Drug Pricing Program Contributes to Rising Healthcare Costs and Is Ripe for Reform
The U.S. House Energy & Commerce Committee's Health Subcommittee today will host the third hearing in its health care affordability series, specifically examining the role providers and hospitals play in shaping the cost of care for Americans.
While the hearing will likely examine numerous issues, there is none more ripe for reform than the flawed 340B drug pricing program.
Originally enacted to help eligible safety-net providers buy medicines at steep discounts and pass the savings on to lower-income and vulnerable patients, the program has ballooned as a revenue stream for many participating hospitals and contract pharmacy chains.
As the size and complexity of the 340B program has expanded, participating hospitals and contract pharmacies have instead used the program to increase…[more]
The government shutdown lasted 40 days before Senate Democrats abandoned the filibuster that closed offices, left workers without paychecks, threatened supplemental food benefits for millions, saw the beginning of a gradual shutdown of the commercial aviation system, and much more. The question is: Why did those Democrats hold out for so long? Why did they stubbornly play a losing hand even as millions of Americans suffered?
The short answer: because Obamacare was at stake. The Affordable Care Act is the Democratic Party's premier policy achievement of the last half-century, and it is gradually…
